Drug details:
Molecular formula: C₁₉H₂₂N₂O₂

Standard name: N-[(E)-(5-tert-butyl-2-hydroxyphenyl)methylideneamino]-4-methylbenzamide

Curated SMILES: CC1=CC=C(C(=O)N/N=C/C2=CC(C(C)(C)C)=CC=C2O)C=C1

Evidence for compound's anti-virulence activity:

Chlamydia
Related VF: TTSS (Type III secretion system)
Target: Not determined
Drug effect: Inhibits T3SS activity.
Max phase: Preclinical (in vitro)
Publication:
Dahlgren MK, et al., 2010. Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia. Bioorg Med Chem 18(7):2686-703.